Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cleft Palate | 7 | 2023 | 79 | 3.160 |
Why?
|
| Cleft Lip | 5 | 2024 | 46 | 2.560 |
Why?
|
| Velopharyngeal Insufficiency | 3 | 2023 | 18 | 1.630 |
Why?
|
| Abnormalities, Multiple | 3 | 2018 | 168 | 1.560 |
Why?
|
| Wound Healing | 2 | 2024 | 221 | 1.170 |
Why?
|
| Surgical Flaps | 3 | 2023 | 110 | 1.170 |
Why?
|
| Postoperative Complications | 4 | 2024 | 1080 | 0.900 |
Why?
|
| Myringoplasty | 1 | 2024 | 6 | 0.890 |
Why?
|
| Tympanic Membrane Perforation | 1 | 2024 | 20 | 0.870 |
Why?
|
| Bites and Stings | 1 | 2024 | 20 | 0.860 |
Why?
|
| Facial Injuries | 1 | 2024 | 25 | 0.860 |
Why?
|
| Cryopreservation | 1 | 2024 | 41 | 0.850 |
Why?
|
| Hemoglobins | 1 | 2024 | 111 | 0.820 |
Why?
|
| Preoperative Care | 1 | 2024 | 174 | 0.780 |
Why?
|
| Pharynx | 3 | 2023 | 31 | 0.780 |
Why?
|
| Reoperation | 2 | 2023 | 464 | 0.760 |
Why?
|
| Pierre Robin Syndrome | 2 | 2021 | 7 | 0.750 |
Why?
|
| Eustachian Tube | 1 | 2021 | 13 | 0.690 |
Why?
|
| Child | 15 | 2024 | 7188 | 0.680 |
Why?
|
| Child, Preschool | 11 | 2024 | 4034 | 0.650 |
Why?
|
| Lip | 2 | 2021 | 11 | 0.620 |
Why?
|
| Uvula | 2 | 2023 | 13 | 0.610 |
Why?
|
| Facial Bones | 1 | 2018 | 18 | 0.590 |
Why?
|
| Craniofacial Abnormalities | 1 | 2018 | 27 | 0.580 |
Why?
|
| Face | 1 | 2018 | 55 | 0.570 |
Why?
|
| Cysts | 1 | 2018 | 51 | 0.550 |
Why?
|
| Treatment Outcome | 10 | 2024 | 5471 | 0.540 |
Why?
|
| Tongue | 2 | 2018 | 40 | 0.530 |
Why?
|
| Infant | 9 | 2024 | 3691 | 0.510 |
Why?
|
| Retrospective Studies | 9 | 2024 | 6643 | 0.490 |
Why?
|
| Quality of Life | 3 | 2018 | 881 | 0.460 |
Why?
|
| Female | 18 | 2024 | 28192 | 0.460 |
Why?
|
| Skin Ulcer | 1 | 2014 | 9 | 0.450 |
Why?
|
| Alginates | 1 | 2014 | 12 | 0.440 |
Why?
|
| Endoscopy | 2 | 2019 | 123 | 0.440 |
Why?
|
| Humans | 26 | 2024 | 52469 | 0.440 |
Why?
|
| Polysaccharides | 1 | 2014 | 54 | 0.430 |
Why?
|
| Silver | 1 | 2014 | 47 | 0.430 |
Why?
|
| Tympanoplasty | 2 | 2014 | 57 | 0.430 |
Why?
|
| Male | 17 | 2024 | 26794 | 0.420 |
Why?
|
| Tracheostomy | 1 | 2014 | 76 | 0.410 |
Why?
|
| Palate | 1 | 2013 | 13 | 0.400 |
Why?
|
| Larynx | 1 | 2013 | 30 | 0.390 |
Why?
|
| Cerebral Palsy | 1 | 2013 | 38 | 0.390 |
Why?
|
| Patient Care Team | 1 | 2014 | 273 | 0.390 |
Why?
|
| Sleep Apnea, Obstructive | 1 | 2013 | 70 | 0.370 |
Why?
|
| Hemangioma | 1 | 2012 | 85 | 0.350 |
Why?
|
| Otitis Media with Effusion | 1 | 2010 | 16 | 0.340 |
Why?
|
| Laryngeal Diseases | 1 | 2010 | 12 | 0.320 |
Why?
|
| Infant, Newborn | 5 | 2018 | 2875 | 0.320 |
Why?
|
| Tracheal Diseases | 1 | 2010 | 13 | 0.320 |
Why?
|
| Trachea | 1 | 2010 | 54 | 0.310 |
Why?
|
| Hearing Loss | 1 | 2010 | 96 | 0.300 |
Why?
|
| Cerebellopontine Angle | 1 | 2008 | 6 | 0.280 |
Why?
|
| Arteriovenous Malformations | 1 | 2009 | 74 | 0.280 |
Why?
|
| Succinate Dehydrogenase | 1 | 2008 | 22 | 0.280 |
Why?
|
| Cerebellar Neoplasms | 1 | 2008 | 21 | 0.280 |
Why?
|
| Paraganglioma | 1 | 2008 | 14 | 0.280 |
Why?
|
| Neuroma, Acoustic | 1 | 2008 | 21 | 0.280 |
Why?
|
| Adolescent | 7 | 2024 | 6708 | 0.270 |
Why?
|
| Neoplasms, Multiple Primary | 1 | 2008 | 44 | 0.270 |
Why?
|
| DNA Mutational Analysis | 1 | 2008 | 180 | 0.270 |
Why?
|
| Follow-Up Studies | 3 | 2018 | 2288 | 0.230 |
Why?
|
| Matrix Attachment Region Binding Proteins | 2 | 2023 | 37 | 0.230 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2008 | 528 | 0.220 |
Why?
|
| Dogs | 1 | 2024 | 183 | 0.210 |
Why?
|
| Umbilical Cord | 1 | 2024 | 36 | 0.210 |
Why?
|
| Prospective Studies | 4 | 2024 | 2449 | 0.210 |
Why?
|
| Clinical Clerkship | 1 | 2023 | 29 | 0.210 |
Why?
|
| Laryngoscopy | 3 | 2014 | 59 | 0.200 |
Why?
|
| Phenotype | 2 | 2023 | 799 | 0.190 |
Why?
|
| Developmental Disabilities | 1 | 2023 | 121 | 0.190 |
Why?
|
| Transcription Factors | 2 | 2023 | 566 | 0.190 |
Why?
|
| Risk Assessment | 3 | 2018 | 1348 | 0.180 |
Why?
|
| Students, Medical | 1 | 2023 | 158 | 0.180 |
Why?
|
| Air Microbiology | 1 | 2020 | 12 | 0.170 |
Why?
|
| Osteogenesis, Distraction | 1 | 2021 | 78 | 0.170 |
Why?
|
| Adenoidectomy | 1 | 2020 | 35 | 0.170 |
Why?
|
| Bronchoscopy | 2 | 2012 | 75 | 0.170 |
Why?
|
| Tonsillectomy | 1 | 2020 | 49 | 0.160 |
Why?
|
| Ambulatory Surgical Procedures | 1 | 2020 | 52 | 0.160 |
Why?
|
| Surgical Wound Infection | 1 | 2020 | 117 | 0.160 |
Why?
|
| Respiratory Tract Infections | 1 | 2020 | 82 | 0.160 |
Why?
|
| Audiovisual Aids | 1 | 2019 | 13 | 0.150 |
Why?
|
| Goldenhar Syndrome | 1 | 2018 | 2 | 0.150 |
Why?
|
| Dental Pulp Cavity | 1 | 2018 | 6 | 0.150 |
Why?
|
| Tooth Abnormalities | 1 | 2018 | 13 | 0.150 |
Why?
|
| Video Recording | 1 | 2019 | 79 | 0.150 |
Why?
|
| Interferon Regulatory Factors | 1 | 2018 | 18 | 0.140 |
Why?
|
| Otolaryngology | 1 | 2019 | 61 | 0.140 |
Why?
|
| Rhinitis | 1 | 2018 | 28 | 0.140 |
Why?
|
| Sinusitis | 1 | 2018 | 42 | 0.140 |
Why?
|
| Head | 2 | 2022 | 71 | 0.120 |
Why?
|
| Pilot Projects | 2 | 2014 | 719 | 0.120 |
Why?
|
| Bandages, Hydrocolloid | 1 | 2014 | 4 | 0.110 |
Why?
|
| Gels | 1 | 2014 | 22 | 0.110 |
Why?
|
| Interdisciplinary Communication | 1 | 2014 | 56 | 0.110 |
Why?
|
| Cartilage | 1 | 2014 | 47 | 0.110 |
Why?
|
| Laryngomalacia | 1 | 2014 | 25 | 0.100 |
Why?
|
| Evidence-Based Medicine | 1 | 2014 | 269 | 0.100 |
Why?
|
| Disease Management | 1 | 2014 | 186 | 0.100 |
Why?
|
| Hospitals, University | 1 | 2013 | 75 | 0.100 |
Why?
|
| Polysomnography | 1 | 2013 | 72 | 0.100 |
Why?
|
| Child Development | 1 | 2014 | 201 | 0.100 |
Why?
|
| Lumbosacral Region | 1 | 2012 | 13 | 0.100 |
Why?
|
| Lasers, Dye | 1 | 2012 | 10 | 0.090 |
Why?
|
| Watchful Waiting | 1 | 2012 | 28 | 0.090 |
Why?
|
| Off-Label Use | 1 | 2012 | 24 | 0.090 |
Why?
|
| Vincristine | 1 | 2012 | 88 | 0.090 |
Why?
|
| Interferon-alpha | 1 | 2012 | 52 | 0.090 |
Why?
|
| Antineoplastic Agents, Phytogenic | 1 | 2012 | 70 | 0.090 |
Why?
|
| Propranolol | 1 | 2012 | 78 | 0.090 |
Why?
|
| Animals | 2 | 2024 | 13455 | 0.090 |
Why?
|
| Adrenergic beta-Antagonists | 1 | 2012 | 112 | 0.090 |
Why?
|
| Practice Guidelines as Topic | 1 | 2014 | 496 | 0.090 |
Why?
|
| Congenital Abnormalities | 1 | 2012 | 118 | 0.090 |
Why?
|
| Recombinant Proteins | 1 | 2012 | 495 | 0.080 |
Why?
|
| Antiviral Agents | 1 | 2012 | 177 | 0.080 |
Why?
|
| Risk Factors | 2 | 2020 | 3945 | 0.080 |
Why?
|
| Syndrome | 2 | 2023 | 252 | 0.080 |
Why?
|
| Diagnosis, Differential | 2 | 2018 | 1044 | 0.080 |
Why?
|
| Fiber Optic Technology | 1 | 2010 | 14 | 0.080 |
Why?
|
| Glucocorticoids | 1 | 2012 | 238 | 0.080 |
Why?
|
| Decision Making | 1 | 2012 | 282 | 0.080 |
Why?
|
| Safety | 1 | 2010 | 80 | 0.080 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2014 | 1162 | 0.080 |
Why?
|
| Recurrence | 1 | 2010 | 682 | 0.080 |
Why?
|
| Head and Neck Neoplasms | 1 | 2012 | 286 | 0.070 |
Why?
|
| Neck | 1 | 2009 | 98 | 0.070 |
Why?
|
| Curriculum | 2 | 2023 | 394 | 0.070 |
Why?
|
| Clinical Competence | 2 | 2023 | 399 | 0.070 |
Why?
|
| Chronic Disease | 1 | 2010 | 588 | 0.070 |
Why?
|
| Young Adult | 3 | 2018 | 4326 | 0.070 |
Why?
|
| Proline | 1 | 2008 | 32 | 0.070 |
Why?
|
| Codon | 1 | 2008 | 43 | 0.070 |
Why?
|
| Amino Acid Substitution | 1 | 2008 | 79 | 0.070 |
Why?
|
| Age Factors | 1 | 2010 | 1131 | 0.070 |
Why?
|
| Leucine | 1 | 2008 | 114 | 0.070 |
Why?
|
| Chromosome Deletion | 1 | 2008 | 140 | 0.070 |
Why?
|
| Alleles | 1 | 2008 | 277 | 0.070 |
Why?
|
| Base Sequence | 1 | 2008 | 634 | 0.060 |
Why?
|
| Radiography | 1 | 2008 | 474 | 0.060 |
Why?
|
| Genotype | 1 | 2008 | 571 | 0.060 |
Why?
|
| Radiosurgery | 1 | 2008 | 129 | 0.060 |
Why?
|
| Severity of Illness Index | 2 | 2023 | 1038 | 0.060 |
Why?
|
| Time Factors | 1 | 2010 | 2989 | 0.050 |
Why?
|
| Sutures | 1 | 2023 | 37 | 0.050 |
Why?
|
| Genetic Association Studies | 1 | 2023 | 123 | 0.050 |
Why?
|
| Personal Satisfaction | 1 | 2022 | 75 | 0.050 |
Why?
|
| Gills | 1 | 2021 | 5 | 0.040 |
Why?
|
| Nasopharynx | 1 | 2020 | 34 | 0.040 |
Why?
|
| Risk | 1 | 2020 | 313 | 0.040 |
Why?
|
| Radiography, Dental | 1 | 2018 | 5 | 0.040 |
Why?
|
| Radiography, Panoramic | 1 | 2018 | 9 | 0.040 |
Why?
|
| Double-Blind Method | 1 | 2020 | 718 | 0.040 |
Why?
|
| Nasal Polyps | 1 | 2018 | 4 | 0.040 |
Why?
|
| Algorithms | 1 | 2021 | 669 | 0.030 |
Why?
|
| Cross-Sectional Studies | 1 | 2022 | 1680 | 0.030 |
Why?
|
| Cohort Studies | 1 | 2020 | 1550 | 0.030 |
Why?
|
| Reproducibility of Results | 1 | 2019 | 1216 | 0.030 |
Why?
|
| Hearing Tests | 1 | 2014 | 27 | 0.030 |
Why?
|
| Hearing | 1 | 2014 | 63 | 0.030 |
Why?
|
| Sickness Impact Profile | 1 | 2014 | 28 | 0.030 |
Why?
|
| Otorhinolaryngologic Surgical Procedures | 1 | 2014 | 34 | 0.030 |
Why?
|
| Glottis | 1 | 2014 | 34 | 0.030 |
Why?
|
| Adult | 1 | 2009 | 14151 | 0.030 |
Why?
|
| United States | 1 | 2023 | 5225 | 0.020 |
Why?
|
| Analysis of Variance | 1 | 2014 | 557 | 0.020 |
Why?
|